nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—type 2 diabetes mellitus—coronary artery disease	0.132	1	CtDrD
Irbesartan—Angiotensin 2 Receptor Antagonists—Telmisartan—coronary artery disease	0.0962	0.37	CiPCiCtD
Irbesartan—Angiotensin 2 Receptor Antagonists—Valsartan—coronary artery disease	0.0818	0.315	CiPCiCtD
Irbesartan—Angiotensin 2 Receptor Antagonists—Losartan—coronary artery disease	0.0818	0.315	CiPCiCtD
Irbesartan—Olmesartan—coronary artery disease	0.0718	0.362	CrCtD
Irbesartan—Valsartan—coronary artery disease	0.0685	0.345	CrCtD
Irbesartan—Losartan—coronary artery disease	0.0582	0.293	CrCtD
Irbesartan—EDNRA—coronary artery disease	0.0505	0.6	CbGaD
Irbesartan—AGTR1—coronary artery disease	0.0337	0.4	CbGaD
Irbesartan—AGTR1—Olmesartan—coronary artery disease	0.0144	0.116	CbGbCtD
Irbesartan—EDNRA—Acetylsalicylic acid—coronary artery disease	0.0135	0.108	CbGbCtD
Irbesartan—AGTR1—Telmisartan—coronary artery disease	0.0115	0.0924	CbGbCtD
Irbesartan—AGTR1—Valsartan—coronary artery disease	0.0112	0.0899	CbGbCtD
Irbesartan—Valsartan—Olmesartan—coronary artery disease	0.0093	0.0699	CrCrCtD
Irbesartan—Forasartan—Olmesartan—coronary artery disease	0.0093	0.0699	CrCrCtD
Irbesartan—Olmesartan—Telmisartan—coronary artery disease	0.00891	0.067	CrCrCtD
Irbesartan—Forasartan—Valsartan—coronary artery disease	0.00887	0.0667	CrCrCtD
Irbesartan—Tasosartan—Olmesartan—coronary artery disease	0.00822	0.0618	CrCrCtD
Irbesartan—Losartan—Telmisartan—coronary artery disease	0.00811	0.061	CrCrCtD
Irbesartan—Tasosartan—Valsartan—coronary artery disease	0.00784	0.0589	CrCrCtD
Irbesartan—Forasartan—Losartan—coronary artery disease	0.00754	0.0567	CrCrCtD
Irbesartan—Valsartan—Losartan—coronary artery disease	0.00754	0.0567	CrCrCtD
Irbesartan—Candesartan—Telmisartan—coronary artery disease	0.00745	0.056	CrCrCtD
Irbesartan—UGT1A3—Pitavastatin—coronary artery disease	0.00715	0.0573	CbGbCtD
Irbesartan—Olmesartan—Valsartan—coronary artery disease	0.00704	0.053	CrCrCtD
Irbesartan—Losartan—Olmesartan—coronary artery disease	0.00672	0.0505	CrCrCtD
Irbesartan—Tasosartan—Losartan—coronary artery disease	0.00667	0.0501	CrCrCtD
Irbesartan—AGTR1—Losartan—coronary artery disease	0.00644	0.0516	CbGbCtD
Irbesartan—Losartan—Valsartan—coronary artery disease	0.00641	0.0482	CrCrCtD
Irbesartan—Candesartan—Olmesartan—coronary artery disease	0.00618	0.0464	CrCrCtD
Irbesartan—Olmesartan—Losartan—coronary artery disease	0.00599	0.045	CrCrCtD
Irbesartan—Candesartan—Valsartan—coronary artery disease	0.00589	0.0443	CrCrCtD
Irbesartan—UGT1A3—Ezetimibe—coronary artery disease	0.00527	0.0422	CbGbCtD
Irbesartan—Candesartan—Losartan—coronary artery disease	0.00501	0.0377	CrCrCtD
Irbesartan—UGT1A3—Simvastatin—coronary artery disease	0.0049	0.0393	CbGbCtD
Irbesartan—UGT1A3—Lovastatin—coronary artery disease	0.0048	0.0384	CbGbCtD
Irbesartan—UGT1A3—Atorvastatin—coronary artery disease	0.00437	0.035	CbGbCtD
Irbesartan—UGT1A3—Losartan—coronary artery disease	0.00399	0.032	CbGbCtD
Irbesartan—CYP2C8—Fenofibrate—coronary artery disease	0.00216	0.0173	CbGbCtD
Irbesartan—CYP2C8—Gemfibrozil—coronary artery disease	0.00173	0.0138	CbGbCtD
Irbesartan—PTGS1—Acetylsalicylic acid—coronary artery disease	0.00163	0.0131	CbGbCtD
Irbesartan—CYP2C9—Fenofibrate—coronary artery disease	0.00151	0.0121	CbGbCtD
Irbesartan—CYP2C8—Clopidogrel—coronary artery disease	0.0015	0.012	CbGbCtD
Irbesartan—CYP1A2—Gemfibrozil—coronary artery disease	0.00134	0.0107	CbGbCtD
Irbesartan—CYP2C8—Pitavastatin—coronary artery disease	0.00131	0.0105	CbGbCtD
Irbesartan—CYP2C9—Gemfibrozil—coronary artery disease	0.0012	0.00965	CbGbCtD
Irbesartan—CYP1A2—Clopidogrel—coronary artery disease	0.00116	0.00929	CbGbCtD
Irbesartan—CYP2C9—cardial valve—coronary artery disease	0.00111	0.176	CbGeAlD
Irbesartan—CYP2C9—Clopidogrel—coronary artery disease	0.00104	0.00837	CbGbCtD
Irbesartan—CYP3A4—Ticagrelor—coronary artery disease	0.000983	0.00788	CbGbCtD
Irbesartan—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.00094	0.00754	CbGbCtD
Irbesartan—CYP2C9—Pitavastatin—coronary artery disease	0.000913	0.00732	CbGbCtD
Irbesartan—CYP2C8—Simvastatin—coronary artery disease	0.000897	0.00719	CbGbCtD
Irbesartan—CYP2C9—Valsartan—coronary artery disease	0.000888	0.00712	CbGbCtD
Irbesartan—CYP2C8—Lovastatin—coronary artery disease	0.000878	0.00704	CbGbCtD
Irbesartan—CYP2C8—Pravastatin—coronary artery disease	0.000878	0.00704	CbGbCtD
Irbesartan—CYP3A4—Fenofibrate—coronary artery disease	0.000876	0.00702	CbGbCtD
Irbesartan—CYP2C8—Atorvastatin—coronary artery disease	0.0008	0.00641	CbGbCtD
Irbesartan—CYP2C8—Losartan—coronary artery disease	0.000731	0.00586	CbGbCtD
Irbesartan—CYP2D6—Niacin—coronary artery disease	0.000724	0.0058	CbGbCtD
Irbesartan—CYP3A4—Gemfibrozil—coronary artery disease	0.0007	0.00561	CbGbCtD
Irbesartan—CYP2C9—Rosuvastatin—coronary artery disease	0.000673	0.00539	CbGbCtD
Irbesartan—CYP2D6—Timolol—coronary artery disease	0.000673	0.00539	CbGbCtD
Irbesartan—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.000656	0.00526	CbGbCtD
Irbesartan—CYP2C9—Simvastatin—coronary artery disease	0.000626	0.00501	CbGbCtD
Irbesartan—CYP2C9—Pravastatin—coronary artery disease	0.000612	0.00491	CbGbCtD
Irbesartan—CYP2C9—Lovastatin—coronary artery disease	0.000612	0.00491	CbGbCtD
Irbesartan—CYP3A4—Clopidogrel—coronary artery disease	0.000607	0.00487	CbGbCtD
Irbesartan—CYP2D6—Captopril—coronary artery disease	0.000592	0.00475	CbGbCtD
Irbesartan—CYP2D6—Simvastatin—coronary artery disease	0.000572	0.00459	CbGbCtD
Irbesartan—CYP1A2—Losartan—coronary artery disease	0.000566	0.00454	CbGbCtD
Irbesartan—CYP3A4—Eplerenone—coronary artery disease	0.000565	0.00452	CbGbCtD
Irbesartan—CYP2D6—Lovastatin—coronary artery disease	0.00056	0.00449	CbGbCtD
Irbesartan—CYP2D6—Pravastatin—coronary artery disease	0.00056	0.00449	CbGbCtD
Irbesartan—CYP2C9—Atorvastatin—coronary artery disease	0.000558	0.00447	CbGbCtD
Irbesartan—CYP2C9—Losartan—coronary artery disease	0.00051	0.00409	CbGbCtD
Irbesartan—CYP2D6—Atorvastatin—coronary artery disease	0.00051	0.00409	CbGbCtD
Irbesartan—CYP3A4—Enalapril—coronary artery disease	0.000503	0.00403	CbGbCtD
Irbesartan—JUN—artery—coronary artery disease	0.000458	0.0728	CbGeAlD
Irbesartan—CYP3A4—Rosuvastatin—coronary artery disease	0.000391	0.00314	CbGbCtD
Irbesartan—CYP3A4—Ezetimibe—coronary artery disease	0.000391	0.00314	CbGbCtD
Irbesartan—JUN—endothelium—coronary artery disease	0.000386	0.0615	CbGeAlD
Irbesartan—CYP3A4—Simvastatin—coronary artery disease	0.000364	0.00292	CbGbCtD
Irbesartan—CYP3A4—Pravastatin—coronary artery disease	0.000356	0.00285	CbGbCtD
Irbesartan—CYP3A4—Lovastatin—coronary artery disease	0.000356	0.00285	CbGbCtD
Irbesartan—AGTR1—artery—coronary artery disease	0.000345	0.0548	CbGeAlD
Irbesartan—CYP3A4—Atorvastatin—coronary artery disease	0.000324	0.0026	CbGbCtD
Irbesartan—CYP3A4—Losartan—coronary artery disease	0.000297	0.00238	CbGbCtD
Irbesartan—AGTR1—endothelium—coronary artery disease	0.000291	0.0463	CbGeAlD
Irbesartan—EDNRA—cardiac ventricle—coronary artery disease	0.000281	0.0448	CbGeAlD
Irbesartan—EDNRA—myocardium—coronary artery disease	0.000265	0.0421	CbGeAlD
Irbesartan—JUN—cardiac ventricle—coronary artery disease	0.000257	0.0408	CbGeAlD
Irbesartan—JUN—myocardium—coronary artery disease	0.000241	0.0384	CbGeAlD
Irbesartan—Forasartan—AGTR1—coronary artery disease	0.000195	0.267	CrCbGaD
Irbesartan—AGTR1—cardiac ventricle—coronary artery disease	0.000193	0.0308	CbGeAlD
Irbesartan—EDNRA—heart—coronary artery disease	0.000185	0.0294	CbGeAlD
Irbesartan—AGTR1—myocardium—coronary artery disease	0.000182	0.0289	CbGeAlD
Irbesartan—JUN—heart—coronary artery disease	0.000168	0.0268	CbGeAlD
Irbesartan—JUN—cardiovascular system—coronary artery disease	0.000159	0.0253	CbGeAlD
Irbesartan—EDNRA—cardiac atrium—coronary artery disease	0.000158	0.0251	CbGeAlD
Irbesartan—PTGS1—artery—coronary artery disease	0.000151	0.0241	CbGeAlD
Irbesartan—JUN—cardiac atrium—coronary artery disease	0.000144	0.0229	CbGeAlD
Irbesartan—PTGS1—endothelium—coronary artery disease	0.000128	0.0204	CbGeAlD
Irbesartan—AGTR1—heart—coronary artery disease	0.000127	0.0202	CbGeAlD
Irbesartan—JUN—blood—coronary artery disease	0.000126	0.02	CbGeAlD
Irbesartan—AGTR1—cardiovascular system—coronary artery disease	0.00012	0.0191	CbGeAlD
Irbesartan—Tasosartan—AGTR1—coronary artery disease	0.000118	0.162	CrCbGaD
Irbesartan—AGTR1—cardiac atrium—coronary artery disease	0.000109	0.0173	CbGeAlD
Irbesartan—Valsartan—AGTR1—coronary artery disease	0.000102	0.14	CrCbGaD
Irbesartan—Olmesartan—AGTR1—coronary artery disease	9.96e-05	0.137	CrCbGaD
Irbesartan—AGTR1—blood—coronary artery disease	9.47e-05	0.0151	CbGeAlD
Irbesartan—PTGS1—myocardium—coronary artery disease	7.99e-05	0.0127	CbGeAlD
Irbesartan—Candesartan—AGTR1—coronary artery disease	7.75e-05	0.106	CrCbGaD
Irbesartan—CYP2C9—heart—coronary artery disease	6.11e-05	0.00972	CbGeAlD
Irbesartan—CYP2C9—cardiovascular system—coronary artery disease	5.77e-05	0.00918	CbGeAlD
Irbesartan—PTGS1—heart—coronary artery disease	5.58e-05	0.00888	CbGeAlD
Irbesartan—PTGS1—cardiovascular system—coronary artery disease	5.26e-05	0.00838	CbGeAlD
Irbesartan—CYP2C8—blood—coronary artery disease	5.13e-05	0.00817	CbGeAlD
Irbesartan—Losartan—AGTR1—coronary artery disease	4.99e-05	0.0686	CrCbGaD
Irbesartan—CYP1A2—blood—coronary artery disease	4.8e-05	0.00765	CbGeAlD
Irbesartan—PTGS1—cardiac atrium—coronary artery disease	4.77e-05	0.00759	CbGeAlD
Irbesartan—CYP2C9—blood—coronary artery disease	4.56e-05	0.00726	CbGeAlD
Irbesartan—PTGS1—blood—coronary artery disease	4.16e-05	0.00663	CbGeAlD
Irbesartan—CYP3A4—blood—coronary artery disease	3.48e-05	0.00553	CbGeAlD
Irbesartan—CYP2D6—blood—coronary artery disease	3.42e-05	0.00545	CbGeAlD
Irbesartan—Losartan—ACE—coronary artery disease	2.88e-05	0.0396	CrCbGaD
Irbesartan—Valsartan—ALB—coronary artery disease	2.42e-05	0.0333	CrCbGaD
Irbesartan—Losartan—CYP2C19—coronary artery disease	2.13e-05	0.0293	CrCbGaD
Irbesartan—Losartan—ALB—coronary artery disease	1.18e-05	0.0162	CrCbGaD
Irbesartan—Rash—Ezetimibe—coronary artery disease	6.8e-06	0.000186	CcSEcCtD
Irbesartan—Dermatitis—Ezetimibe—coronary artery disease	6.8e-06	0.000186	CcSEcCtD
Irbesartan—Discomfort—Timolol—coronary artery disease	6.79e-06	0.000186	CcSEcCtD
Irbesartan—Asthenia—Niacin—coronary artery disease	6.78e-06	0.000186	CcSEcCtD
Irbesartan—Fatigue—Losartan—coronary artery disease	6.77e-06	0.000186	CcSEcCtD
Irbesartan—Headache—Ezetimibe—coronary artery disease	6.76e-06	0.000185	CcSEcCtD
Irbesartan—Malaise—Lisinopril—coronary artery disease	6.75e-06	0.000185	CcSEcCtD
Irbesartan—Oedema—Ramipril—coronary artery disease	6.74e-06	0.000184	CcSEcCtD
Irbesartan—Anaphylactic shock—Ramipril—coronary artery disease	6.74e-06	0.000184	CcSEcCtD
Irbesartan—Vertigo—Lisinopril—coronary artery disease	6.73e-06	0.000184	CcSEcCtD
Irbesartan—Dry mouth—Timolol—coronary artery disease	6.72e-06	0.000184	CcSEcCtD
Irbesartan—Pain—Losartan—coronary artery disease	6.72e-06	0.000184	CcSEcCtD
Irbesartan—Constipation—Losartan—coronary artery disease	6.72e-06	0.000184	CcSEcCtD
Irbesartan—Syncope—Lisinopril—coronary artery disease	6.71e-06	0.000184	CcSEcCtD
Irbesartan—Vomiting—Eplerenone—coronary artery disease	6.71e-06	0.000184	CcSEcCtD
Irbesartan—Feeling abnormal—Furosemide—coronary artery disease	6.71e-06	0.000184	CcSEcCtD
Irbesartan—Leukopenia—Lisinopril—coronary artery disease	6.7e-06	0.000184	CcSEcCtD
Irbesartan—Nausea—Fenofibrate—coronary artery disease	6.69e-06	0.000183	CcSEcCtD
Irbesartan—Pruritus—Niacin—coronary artery disease	6.68e-06	0.000183	CcSEcCtD
Irbesartan—Asthenia—Pravastatin—coronary artery disease	6.67e-06	0.000183	CcSEcCtD
Irbesartan—Gastrointestinal pain—Furosemide—coronary artery disease	6.66e-06	0.000182	CcSEcCtD
Irbesartan—Rash—Eplerenone—coronary artery disease	6.66e-06	0.000182	CcSEcCtD
Irbesartan—Urticaria—Perindopril—coronary artery disease	6.66e-06	0.000182	CcSEcCtD
Irbesartan—Hypersensitivity—Trandolapril—coronary artery disease	6.65e-06	0.000182	CcSEcCtD
Irbesartan—Dermatitis—Eplerenone—coronary artery disease	6.65e-06	0.000182	CcSEcCtD
Irbesartan—Diarrhoea—Valsartan—coronary artery disease	6.65e-06	0.000182	CcSEcCtD
Irbesartan—Shock—Ramipril—coronary artery disease	6.63e-06	0.000182	CcSEcCtD
Irbesartan—Hypersensitivity—Enalapril—coronary artery disease	6.63e-06	0.000181	CcSEcCtD
Irbesartan—Abdominal pain—Perindopril—coronary artery disease	6.62e-06	0.000181	CcSEcCtD
Irbesartan—Body temperature increased—Perindopril—coronary artery disease	6.62e-06	0.000181	CcSEcCtD
Irbesartan—Diarrhoea—Olmesartan—coronary artery disease	6.62e-06	0.000181	CcSEcCtD
Irbesartan—Headache—Eplerenone—coronary artery disease	6.62e-06	0.000181	CcSEcCtD
Irbesartan—Nervous system disorder—Ramipril—coronary artery disease	6.61e-06	0.000181	CcSEcCtD
Irbesartan—Thrombocytopenia—Ramipril—coronary artery disease	6.6e-06	0.000181	CcSEcCtD
Irbesartan—Oedema—Timolol—coronary artery disease	6.59e-06	0.00018	CcSEcCtD
Irbesartan—Anaphylactic shock—Timolol—coronary artery disease	6.59e-06	0.00018	CcSEcCtD
Irbesartan—Pruritus—Pravastatin—coronary artery disease	6.58e-06	0.00018	CcSEcCtD
Irbesartan—Loss of consciousness—Lisinopril—coronary artery disease	6.58e-06	0.00018	CcSEcCtD
Irbesartan—Nausea—Clopidogrel—coronary artery disease	6.58e-06	0.00018	CcSEcCtD
Irbesartan—Tachycardia—Ramipril—coronary artery disease	6.58e-06	0.00018	CcSEcCtD
Irbesartan—Skin disorder—Ramipril—coronary artery disease	6.54e-06	0.000179	CcSEcCtD
Irbesartan—Infection—Timolol—coronary artery disease	6.54e-06	0.000179	CcSEcCtD
Irbesartan—Vomiting—Simvastatin—coronary artery disease	6.54e-06	0.000179	CcSEcCtD
Irbesartan—Hypersensitivity—Telmisartan—coronary artery disease	6.54e-06	0.000179	CcSEcCtD
Irbesartan—Cough—Lisinopril—coronary artery disease	6.53e-06	0.000179	CcSEcCtD
Irbesartan—Nausea—Lovastatin—coronary artery disease	6.53e-06	0.000179	CcSEcCtD
Irbesartan—Hyperhidrosis—Ramipril—coronary artery disease	6.51e-06	0.000178	CcSEcCtD
Irbesartan—Rash—Simvastatin—coronary artery disease	6.49e-06	0.000178	CcSEcCtD
Irbesartan—Dermatitis—Simvastatin—coronary artery disease	6.48e-06	0.000177	CcSEcCtD
Irbesartan—Asthenia—Trandolapril—coronary artery disease	6.48e-06	0.000177	CcSEcCtD
Irbesartan—Shock—Timolol—coronary artery disease	6.48e-06	0.000177	CcSEcCtD
Irbesartan—Feeling abnormal—Losartan—coronary artery disease	6.48e-06	0.000177	CcSEcCtD
Irbesartan—Urticaria—Furosemide—coronary artery disease	6.47e-06	0.000177	CcSEcCtD
Irbesartan—Diarrhoea—Niacin—coronary artery disease	6.46e-06	0.000177	CcSEcCtD
Irbesartan—Nervous system disorder—Timolol—coronary artery disease	6.46e-06	0.000177	CcSEcCtD
Irbesartan—Asthenia—Enalapril—coronary artery disease	6.45e-06	0.000177	CcSEcCtD
Irbesartan—Headache—Simvastatin—coronary artery disease	6.45e-06	0.000176	CcSEcCtD
Irbesartan—Abdominal pain—Furosemide—coronary artery disease	6.44e-06	0.000176	CcSEcCtD
Irbesartan—Body temperature increased—Furosemide—coronary artery disease	6.44e-06	0.000176	CcSEcCtD
Irbesartan—Gastrointestinal pain—Losartan—coronary artery disease	6.43e-06	0.000176	CcSEcCtD
Irbesartan—Dizziness—Valsartan—coronary artery disease	6.42e-06	0.000176	CcSEcCtD
Irbesartan—Anorexia—Ramipril—coronary artery disease	6.42e-06	0.000176	CcSEcCtD
Irbesartan—Nausea—Ezetimibe—coronary artery disease	6.41e-06	0.000175	CcSEcCtD
Irbesartan—Skin disorder—Timolol—coronary artery disease	6.4e-06	0.000175	CcSEcCtD
Irbesartan—Dizziness—Olmesartan—coronary artery disease	6.39e-06	0.000175	CcSEcCtD
Irbesartan—Pruritus—Trandolapril—coronary artery disease	6.39e-06	0.000175	CcSEcCtD
Irbesartan—Chest pain—Lisinopril—coronary artery disease	6.37e-06	0.000175	CcSEcCtD
Irbesartan—Arthralgia—Lisinopril—coronary artery disease	6.37e-06	0.000175	CcSEcCtD
Irbesartan—Myalgia—Lisinopril—coronary artery disease	6.37e-06	0.000175	CcSEcCtD
Irbesartan—Hyperhidrosis—Timolol—coronary artery disease	6.37e-06	0.000174	CcSEcCtD
Irbesartan—Asthenia—Telmisartan—coronary artery disease	6.37e-06	0.000174	CcSEcCtD
Irbesartan—Pruritus—Enalapril—coronary artery disease	6.36e-06	0.000174	CcSEcCtD
Irbesartan—Diarrhoea—Pravastatin—coronary artery disease	6.36e-06	0.000174	CcSEcCtD
Irbesartan—Anxiety—Lisinopril—coronary artery disease	6.35e-06	0.000174	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	6.33e-06	0.000173	CcSEcCtD
Irbesartan—Discomfort—Lisinopril—coronary artery disease	6.3e-06	0.000172	CcSEcCtD
Irbesartan—Hypotension—Ramipril—coronary artery disease	6.3e-06	0.000172	CcSEcCtD
Irbesartan—Anorexia—Timolol—coronary artery disease	6.28e-06	0.000172	CcSEcCtD
Irbesartan—Pruritus—Telmisartan—coronary artery disease	6.28e-06	0.000172	CcSEcCtD
Irbesartan—Nausea—Eplerenone—coronary artery disease	6.27e-06	0.000172	CcSEcCtD
Irbesartan—Dizziness—Niacin—coronary artery disease	6.25e-06	0.000171	CcSEcCtD
Irbesartan—Urticaria—Losartan—coronary artery disease	6.24e-06	0.000171	CcSEcCtD
Irbesartan—Dry mouth—Lisinopril—coronary artery disease	6.23e-06	0.000171	CcSEcCtD
Irbesartan—Abdominal pain—Losartan—coronary artery disease	6.21e-06	0.00017	CcSEcCtD
Irbesartan—Body temperature increased—Losartan—coronary artery disease	6.21e-06	0.00017	CcSEcCtD
Irbesartan—Asthenia—Captopril—coronary artery disease	6.19e-06	0.00017	CcSEcCtD
Irbesartan—Diarrhoea—Trandolapril—coronary artery disease	6.18e-06	0.000169	CcSEcCtD
Irbesartan—Vomiting—Valsartan—coronary artery disease	6.18e-06	0.000169	CcSEcCtD
Irbesartan—Diarrhoea—Enalapril—coronary artery disease	6.16e-06	0.000169	CcSEcCtD
Irbesartan—Hypotension—Timolol—coronary artery disease	6.16e-06	0.000169	CcSEcCtD
Irbesartan—Dizziness—Pravastatin—coronary artery disease	6.15e-06	0.000168	CcSEcCtD
Irbesartan—Vomiting—Olmesartan—coronary artery disease	6.15e-06	0.000168	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Ramipril—coronary artery disease	6.14e-06	0.000168	CcSEcCtD
Irbesartan—Rash—Valsartan—coronary artery disease	6.13e-06	0.000168	CcSEcCtD
Irbesartan—Dermatitis—Valsartan—coronary artery disease	6.12e-06	0.000168	CcSEcCtD
Irbesartan—Nausea—Simvastatin—coronary artery disease	6.11e-06	0.000167	CcSEcCtD
Irbesartan—Anaphylactic shock—Lisinopril—coronary artery disease	6.11e-06	0.000167	CcSEcCtD
Irbesartan—Oedema—Lisinopril—coronary artery disease	6.11e-06	0.000167	CcSEcCtD
Irbesartan—Pruritus—Captopril—coronary artery disease	6.1e-06	0.000167	CcSEcCtD
Irbesartan—Rash—Olmesartan—coronary artery disease	6.1e-06	0.000167	CcSEcCtD
Irbesartan—Dermatitis—Olmesartan—coronary artery disease	6.09e-06	0.000167	CcSEcCtD
Irbesartan—Headache—Valsartan—coronary artery disease	6.09e-06	0.000167	CcSEcCtD
Irbesartan—Diarrhoea—Telmisartan—coronary artery disease	6.07e-06	0.000166	CcSEcCtD
Irbesartan—Infection—Lisinopril—coronary artery disease	6.07e-06	0.000166	CcSEcCtD
Irbesartan—Headache—Olmesartan—coronary artery disease	6.06e-06	0.000166	CcSEcCtD
Irbesartan—Paraesthesia—Ramipril—coronary artery disease	6.05e-06	0.000166	CcSEcCtD
Irbesartan—Shock—Lisinopril—coronary artery disease	6.01e-06	0.000165	CcSEcCtD
Irbesartan—Asthenia—Perindopril—coronary artery disease	6.01e-06	0.000165	CcSEcCtD
Irbesartan—Dyspnoea—Ramipril—coronary artery disease	6.01e-06	0.000164	CcSEcCtD
Irbesartan—Vomiting—Niacin—coronary artery disease	6.01e-06	0.000164	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Timolol—coronary artery disease	6e-06	0.000164	CcSEcCtD
Irbesartan—Hypersensitivity—Furosemide—coronary artery disease	6e-06	0.000164	CcSEcCtD
Irbesartan—Somnolence—Ramipril—coronary artery disease	5.99e-06	0.000164	CcSEcCtD
Irbesartan—Thrombocytopenia—Lisinopril—coronary artery disease	5.98e-06	0.000164	CcSEcCtD
Irbesartan—Dizziness—Trandolapril—coronary artery disease	5.97e-06	0.000164	CcSEcCtD
Irbesartan—Tachycardia—Lisinopril—coronary artery disease	5.96e-06	0.000163	CcSEcCtD
Irbesartan—Rash—Niacin—coronary artery disease	5.96e-06	0.000163	CcSEcCtD
Irbesartan—Dermatitis—Niacin—coronary artery disease	5.95e-06	0.000163	CcSEcCtD
Irbesartan—Dizziness—Enalapril—coronary artery disease	5.95e-06	0.000163	CcSEcCtD
Irbesartan—Skin disorder—Lisinopril—coronary artery disease	5.94e-06	0.000163	CcSEcCtD
Irbesartan—Dyspepsia—Ramipril—coronary artery disease	5.93e-06	0.000162	CcSEcCtD
Irbesartan—Pruritus—Perindopril—coronary artery disease	5.93e-06	0.000162	CcSEcCtD
Irbesartan—Headache—Niacin—coronary artery disease	5.92e-06	0.000162	CcSEcCtD
Irbesartan—Paraesthesia—Timolol—coronary artery disease	5.91e-06	0.000162	CcSEcCtD
Irbesartan—Vomiting—Pravastatin—coronary artery disease	5.91e-06	0.000162	CcSEcCtD
Irbesartan—Hyperhidrosis—Lisinopril—coronary artery disease	5.91e-06	0.000162	CcSEcCtD
Irbesartan—Diarrhoea—Captopril—coronary artery disease	5.9e-06	0.000162	CcSEcCtD
Irbesartan—Dyspnoea—Timolol—coronary artery disease	5.87e-06	0.000161	CcSEcCtD
Irbesartan—Dizziness—Telmisartan—coronary artery disease	5.87e-06	0.000161	CcSEcCtD
Irbesartan—Rash—Pravastatin—coronary artery disease	5.86e-06	0.000161	CcSEcCtD
Irbesartan—Dermatitis—Pravastatin—coronary artery disease	5.86e-06	0.00016	CcSEcCtD
Irbesartan—Decreased appetite—Ramipril—coronary artery disease	5.86e-06	0.00016	CcSEcCtD
Irbesartan—Somnolence—Timolol—coronary artery disease	5.86e-06	0.00016	CcSEcCtD
Irbesartan—Asthenia—Furosemide—coronary artery disease	5.84e-06	0.00016	CcSEcCtD
Irbesartan—Headache—Pravastatin—coronary artery disease	5.83e-06	0.00016	CcSEcCtD
Irbesartan—Anorexia—Lisinopril—coronary artery disease	5.82e-06	0.000159	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Ramipril—coronary artery disease	5.82e-06	0.000159	CcSEcCtD
Irbesartan—Fatigue—Ramipril—coronary artery disease	5.81e-06	0.000159	CcSEcCtD
Irbesartan—Dyspepsia—Timolol—coronary artery disease	5.8e-06	0.000159	CcSEcCtD
Irbesartan—Hypersensitivity—Losartan—coronary artery disease	5.79e-06	0.000159	CcSEcCtD
Irbesartan—Nausea—Valsartan—coronary artery disease	5.77e-06	0.000158	CcSEcCtD
Irbesartan—Pruritus—Furosemide—coronary artery disease	5.76e-06	0.000158	CcSEcCtD
Irbesartan—Constipation—Ramipril—coronary artery disease	5.76e-06	0.000158	CcSEcCtD
Irbesartan—Nausea—Olmesartan—coronary artery disease	5.74e-06	0.000157	CcSEcCtD
Irbesartan—Vomiting—Trandolapril—coronary artery disease	5.74e-06	0.000157	CcSEcCtD
Irbesartan—Diarrhoea—Perindopril—coronary artery disease	5.73e-06	0.000157	CcSEcCtD
Irbesartan—Decreased appetite—Timolol—coronary artery disease	5.73e-06	0.000157	CcSEcCtD
Irbesartan—Vomiting—Enalapril—coronary artery disease	5.72e-06	0.000157	CcSEcCtD
Irbesartan—Hypotension—Lisinopril—coronary artery disease	5.71e-06	0.000156	CcSEcCtD
Irbesartan—Dizziness—Captopril—coronary artery disease	5.71e-06	0.000156	CcSEcCtD
Irbesartan—Rash—Trandolapril—coronary artery disease	5.7e-06	0.000156	CcSEcCtD
Irbesartan—Dermatitis—Trandolapril—coronary artery disease	5.69e-06	0.000156	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Timolol—coronary artery disease	5.69e-06	0.000156	CcSEcCtD
Irbesartan—Fatigue—Timolol—coronary artery disease	5.68e-06	0.000156	CcSEcCtD
Irbesartan—Rash—Enalapril—coronary artery disease	5.67e-06	0.000155	CcSEcCtD
Irbesartan—Dermatitis—Enalapril—coronary artery disease	5.67e-06	0.000155	CcSEcCtD
Irbesartan—Headache—Trandolapril—coronary artery disease	5.66e-06	0.000155	CcSEcCtD
Irbesartan—Vomiting—Telmisartan—coronary artery disease	5.64e-06	0.000154	CcSEcCtD
Irbesartan—Asthenia—Losartan—coronary artery disease	5.64e-06	0.000154	CcSEcCtD
Irbesartan—Headache—Enalapril—coronary artery disease	5.64e-06	0.000154	CcSEcCtD
Irbesartan—Pain—Timolol—coronary artery disease	5.63e-06	0.000154	CcSEcCtD
Irbesartan—Nausea—Niacin—coronary artery disease	5.61e-06	0.000154	CcSEcCtD
Irbesartan—Rash—Telmisartan—coronary artery disease	5.59e-06	0.000153	CcSEcCtD
Irbesartan—Dermatitis—Telmisartan—coronary artery disease	5.59e-06	0.000153	CcSEcCtD
Irbesartan—Diarrhoea—Furosemide—coronary artery disease	5.57e-06	0.000153	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Lisinopril—coronary artery disease	5.57e-06	0.000152	CcSEcCtD
Irbesartan—Pruritus—Losartan—coronary artery disease	5.56e-06	0.000152	CcSEcCtD
Irbesartan—Headache—Telmisartan—coronary artery disease	5.56e-06	0.000152	CcSEcCtD
Irbesartan—Feeling abnormal—Ramipril—coronary artery disease	5.55e-06	0.000152	CcSEcCtD
Irbesartan—Dizziness—Perindopril—coronary artery disease	5.54e-06	0.000152	CcSEcCtD
Irbesartan—Nausea—Pravastatin—coronary artery disease	5.53e-06	0.000151	CcSEcCtD
Irbesartan—Gastrointestinal pain—Ramipril—coronary artery disease	5.51e-06	0.000151	CcSEcCtD
Irbesartan—Paraesthesia—Lisinopril—coronary artery disease	5.49e-06	0.00015	CcSEcCtD
Irbesartan—Vomiting—Captopril—coronary artery disease	5.49e-06	0.00015	CcSEcCtD
Irbesartan—Dyspnoea—Lisinopril—coronary artery disease	5.45e-06	0.000149	CcSEcCtD
Irbesartan—Rash—Captopril—coronary artery disease	5.44e-06	0.000149	CcSEcCtD
Irbesartan—Dermatitis—Captopril—coronary artery disease	5.44e-06	0.000149	CcSEcCtD
Irbesartan—Somnolence—Lisinopril—coronary artery disease	5.43e-06	0.000149	CcSEcCtD
Irbesartan—Feeling abnormal—Timolol—coronary artery disease	5.43e-06	0.000149	CcSEcCtD
Irbesartan—Headache—Captopril—coronary artery disease	5.41e-06	0.000148	CcSEcCtD
Irbesartan—Gastrointestinal pain—Timolol—coronary artery disease	5.39e-06	0.000147	CcSEcCtD
Irbesartan—Dizziness—Furosemide—coronary artery disease	5.39e-06	0.000147	CcSEcCtD
Irbesartan—Dyspepsia—Lisinopril—coronary artery disease	5.38e-06	0.000147	CcSEcCtD
Irbesartan—Diarrhoea—Losartan—coronary artery disease	5.38e-06	0.000147	CcSEcCtD
Irbesartan—Nausea—Trandolapril—coronary artery disease	5.37e-06	0.000147	CcSEcCtD
Irbesartan—Urticaria—Ramipril—coronary artery disease	5.35e-06	0.000147	CcSEcCtD
Irbesartan—Nausea—Enalapril—coronary artery disease	5.34e-06	0.000146	CcSEcCtD
Irbesartan—Vomiting—Perindopril—coronary artery disease	5.33e-06	0.000146	CcSEcCtD
Irbesartan—Body temperature increased—Ramipril—coronary artery disease	5.33e-06	0.000146	CcSEcCtD
Irbesartan—Abdominal pain—Ramipril—coronary artery disease	5.33e-06	0.000146	CcSEcCtD
Irbesartan—Decreased appetite—Lisinopril—coronary artery disease	5.31e-06	0.000145	CcSEcCtD
Irbesartan—Rash—Perindopril—coronary artery disease	5.28e-06	0.000145	CcSEcCtD
Irbesartan—Dermatitis—Perindopril—coronary artery disease	5.28e-06	0.000145	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Lisinopril—coronary artery disease	5.28e-06	0.000144	CcSEcCtD
Irbesartan—Nausea—Telmisartan—coronary artery disease	5.27e-06	0.000144	CcSEcCtD
Irbesartan—Fatigue—Lisinopril—coronary artery disease	5.27e-06	0.000144	CcSEcCtD
Irbesartan—Headache—Perindopril—coronary artery disease	5.25e-06	0.000144	CcSEcCtD
Irbesartan—Urticaria—Timolol—coronary artery disease	5.23e-06	0.000143	CcSEcCtD
Irbesartan—Pain—Lisinopril—coronary artery disease	5.23e-06	0.000143	CcSEcCtD
Irbesartan—Constipation—Lisinopril—coronary artery disease	5.23e-06	0.000143	CcSEcCtD
Irbesartan—Body temperature increased—Timolol—coronary artery disease	5.21e-06	0.000143	CcSEcCtD
Irbesartan—Abdominal pain—Timolol—coronary artery disease	5.21e-06	0.000143	CcSEcCtD
Irbesartan—Dizziness—Losartan—coronary artery disease	5.2e-06	0.000142	CcSEcCtD
Irbesartan—Vomiting—Furosemide—coronary artery disease	5.18e-06	0.000142	CcSEcCtD
Irbesartan—Rash—Furosemide—coronary artery disease	5.14e-06	0.000141	CcSEcCtD
Irbesartan—Dermatitis—Furosemide—coronary artery disease	5.13e-06	0.00014	CcSEcCtD
Irbesartan—Nausea—Captopril—coronary artery disease	5.13e-06	0.00014	CcSEcCtD
Irbesartan—Headache—Furosemide—coronary artery disease	5.1e-06	0.00014	CcSEcCtD
Irbesartan—Feeling abnormal—Lisinopril—coronary artery disease	5.04e-06	0.000138	CcSEcCtD
Irbesartan—Gastrointestinal pain—Lisinopril—coronary artery disease	5e-06	0.000137	CcSEcCtD
Irbesartan—Vomiting—Losartan—coronary artery disease	5e-06	0.000137	CcSEcCtD
Irbesartan—Nausea—Perindopril—coronary artery disease	4.98e-06	0.000136	CcSEcCtD
Irbesartan—Hypersensitivity—Ramipril—coronary artery disease	4.96e-06	0.000136	CcSEcCtD
Irbesartan—Rash—Losartan—coronary artery disease	4.95e-06	0.000136	CcSEcCtD
Irbesartan—Dermatitis—Losartan—coronary artery disease	4.95e-06	0.000136	CcSEcCtD
Irbesartan—Headache—Losartan—coronary artery disease	4.92e-06	0.000135	CcSEcCtD
Irbesartan—Urticaria—Lisinopril—coronary artery disease	4.85e-06	0.000133	CcSEcCtD
Irbesartan—Hypersensitivity—Timolol—coronary artery disease	4.85e-06	0.000133	CcSEcCtD
Irbesartan—Nausea—Furosemide—coronary artery disease	4.84e-06	0.000132	CcSEcCtD
Irbesartan—Asthenia—Ramipril—coronary artery disease	4.83e-06	0.000132	CcSEcCtD
Irbesartan—Abdominal pain—Lisinopril—coronary artery disease	4.83e-06	0.000132	CcSEcCtD
Irbesartan—Body temperature increased—Lisinopril—coronary artery disease	4.83e-06	0.000132	CcSEcCtD
Irbesartan—Pruritus—Ramipril—coronary artery disease	4.77e-06	0.000131	CcSEcCtD
Irbesartan—Asthenia—Timolol—coronary artery disease	4.73e-06	0.000129	CcSEcCtD
Irbesartan—Nausea—Losartan—coronary artery disease	4.67e-06	0.000128	CcSEcCtD
Irbesartan—Pruritus—Timolol—coronary artery disease	4.66e-06	0.000128	CcSEcCtD
Irbesartan—Diarrhoea—Ramipril—coronary artery disease	4.61e-06	0.000126	CcSEcCtD
Irbesartan—Diarrhoea—Timolol—coronary artery disease	4.51e-06	0.000123	CcSEcCtD
Irbesartan—Hypersensitivity—Lisinopril—coronary artery disease	4.5e-06	0.000123	CcSEcCtD
Irbesartan—Dizziness—Ramipril—coronary artery disease	4.46e-06	0.000122	CcSEcCtD
Irbesartan—Asthenia—Lisinopril—coronary artery disease	4.38e-06	0.00012	CcSEcCtD
Irbesartan—Dizziness—Timolol—coronary artery disease	4.36e-06	0.000119	CcSEcCtD
Irbesartan—Pruritus—Lisinopril—coronary artery disease	4.32e-06	0.000118	CcSEcCtD
Irbesartan—Vomiting—Ramipril—coronary artery disease	4.28e-06	0.000117	CcSEcCtD
Irbesartan—Rash—Ramipril—coronary artery disease	4.25e-06	0.000116	CcSEcCtD
Irbesartan—Dermatitis—Ramipril—coronary artery disease	4.24e-06	0.000116	CcSEcCtD
Irbesartan—Headache—Ramipril—coronary artery disease	4.22e-06	0.000116	CcSEcCtD
Irbesartan—Vomiting—Timolol—coronary artery disease	4.19e-06	0.000115	CcSEcCtD
Irbesartan—Diarrhoea—Lisinopril—coronary artery disease	4.18e-06	0.000114	CcSEcCtD
Irbesartan—Rash—Timolol—coronary artery disease	4.15e-06	0.000114	CcSEcCtD
Irbesartan—Dermatitis—Timolol—coronary artery disease	4.15e-06	0.000114	CcSEcCtD
Irbesartan—Headache—Timolol—coronary artery disease	4.13e-06	0.000113	CcSEcCtD
Irbesartan—Dizziness—Lisinopril—coronary artery disease	4.04e-06	0.000111	CcSEcCtD
Irbesartan—Nausea—Ramipril—coronary artery disease	4e-06	0.00011	CcSEcCtD
Irbesartan—Nausea—Timolol—coronary artery disease	3.91e-06	0.000107	CcSEcCtD
Irbesartan—Vomiting—Lisinopril—coronary artery disease	3.89e-06	0.000106	CcSEcCtD
Irbesartan—Rash—Lisinopril—coronary artery disease	3.85e-06	0.000105	CcSEcCtD
Irbesartan—Dermatitis—Lisinopril—coronary artery disease	3.85e-06	0.000105	CcSEcCtD
Irbesartan—Headache—Lisinopril—coronary artery disease	3.83e-06	0.000105	CcSEcCtD
Irbesartan—Nausea—Lisinopril—coronary artery disease	3.63e-06	9.94e-05	CcSEcCtD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.4e-07	1.77e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCND1—coronary artery disease	4.39e-07	1.77e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MAPK1—coronary artery disease	4.39e-07	1.77e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GCLC—coronary artery disease	4.39e-07	1.77e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CETP—coronary artery disease	4.39e-07	1.77e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IGF1—coronary artery disease	4.38e-07	1.77e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—SDC1—coronary artery disease	4.38e-07	1.77e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—APOA1—coronary artery disease	4.37e-07	1.76e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ABCA1—coronary artery disease	4.34e-07	1.75e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—SDC1—coronary artery disease	4.34e-07	1.75e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—TXNRD1—coronary artery disease	4.3e-07	1.73e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYP11B2—coronary artery disease	4.3e-07	1.73e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MMP9—coronary artery disease	4.26e-07	1.72e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—VCAN—coronary artery disease	4.25e-07	1.72e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SLC22A3—coronary artery disease	4.23e-07	1.71e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALDOA—coronary artery disease	4.22e-07	1.7e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GGT1—coronary artery disease	4.21e-07	1.7e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GOT1—coronary artery disease	4.21e-07	1.7e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.19e-07	1.69e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ARNTL—coronary artery disease	4.17e-07	1.68e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—HADH—coronary artery disease	4.17e-07	1.68e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SERPINE1—coronary artery disease	4.16e-07	1.68e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—AKT1—coronary artery disease	4.13e-07	1.67e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PSMB5—coronary artery disease	4.13e-07	1.67e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PSMA6—coronary artery disease	4.13e-07	1.67e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—DCN—coronary artery disease	4.1e-07	1.65e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PSMB5—coronary artery disease	4.1e-07	1.65e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PSMA6—coronary artery disease	4.1e-07	1.65e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	4.09e-07	1.65e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CTGF—coronary artery disease	4.04e-07	1.63e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—FGF2—coronary artery disease	4.03e-07	1.62e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CTGF—coronary artery disease	4e-07	1.62e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—HMGCR—coronary artery disease	4e-07	1.61e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GOT2—coronary artery disease	4e-07	1.61e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALDH2—coronary artery disease	3.99e-07	1.61e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—MAPK1—coronary artery disease	3.98e-07	1.61e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NOS3—coronary artery disease	3.97e-07	1.6e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—HMGCR—coronary artery disease	3.97e-07	1.6e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GOT2—coronary artery disease	3.97e-07	1.6e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOA2—coronary artery disease	3.96e-07	1.6e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	3.96e-07	1.6e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GPX2—coronary artery disease	3.96e-07	1.6e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GPX4—coronary artery disease	3.91e-07	1.58e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SULT1A1—coronary artery disease	3.91e-07	1.58e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—HK1—coronary artery disease	3.91e-07	1.58e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ABCG5—coronary artery disease	3.91e-07	1.58e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	3.89e-07	1.57e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—LIPC—coronary artery disease	3.89e-07	1.57e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—HBA1—coronary artery disease	3.89e-07	1.57e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CYP2C19—coronary artery disease	3.89e-07	1.57e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	3.89e-07	1.57e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—HADHA—coronary artery disease	3.86e-07	1.56e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOC3—coronary artery disease	3.86e-07	1.56e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—JAK2—coronary artery disease	3.86e-07	1.56e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PPARG—coronary artery disease	3.85e-07	1.55e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—LDLR—coronary artery disease	3.84e-07	1.55e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	3.83e-07	1.55e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—VEGFA—coronary artery disease	3.83e-07	1.54e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GSTA1—coronary artery disease	3.82e-07	1.54e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—PIK3CA—coronary artery disease	3.81e-07	1.54e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—POMC—coronary artery disease	3.8e-07	1.53e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—SLC9A1—coronary artery disease	3.79e-07	1.53e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GSTT1—coronary artery disease	3.79e-07	1.53e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GSTP1—coronary artery disease	3.78e-07	1.53e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—LPA—coronary artery disease	3.77e-07	1.52e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GCLC—coronary artery disease	3.75e-07	1.51e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CETP—coronary artery disease	3.75e-07	1.51e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	3.74e-07	1.51e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—HMOX1—coronary artery disease	3.73e-07	1.5e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—SDC1—coronary artery disease	3.71e-07	1.5e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PLCB1—coronary artery disease	3.68e-07	1.48e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CAT—coronary artery disease	3.68e-07	1.48e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PLCB3—coronary artery disease	3.66e-07	1.48e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PLCB1—coronary artery disease	3.65e-07	1.47e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOA5—coronary artery disease	3.62e-07	1.46e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.58e-07	1.44e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—APOB—coronary artery disease	3.57e-07	1.44e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ABCA1—coronary artery disease	3.57e-07	1.44e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—P4HB—coronary artery disease	3.55e-07	1.43e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ABCA1—coronary artery disease	3.54e-07	1.43e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCL8—coronary artery disease	3.52e-07	1.42e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TGFB1—coronary artery disease	3.51e-07	1.42e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PSMA6—coronary artery disease	3.5e-07	1.41e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PSMB5—coronary artery disease	3.5e-07	1.41e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	3.5e-07	1.41e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	3.48e-07	1.41e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GSTM1—coronary artery disease	3.47e-07	1.4e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ALB—coronary artery disease	3.46e-07	1.4e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—PIK3CA—coronary artery disease	3.46e-07	1.39e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GOT1—coronary artery disease	3.45e-07	1.39e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GGT1—coronary artery disease	3.45e-07	1.39e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MAPK1—coronary artery disease	3.45e-07	1.39e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GGT1—coronary artery disease	3.42e-07	1.38e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GOT1—coronary artery disease	3.42e-07	1.38e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CTGF—coronary artery disease	3.42e-07	1.38e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—LPL—coronary artery disease	3.41e-07	1.38e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—HMGCR—coronary artery disease	3.39e-07	1.37e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GOT2—coronary artery disease	3.39e-07	1.37e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL6—coronary artery disease	3.37e-07	1.36e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CASP3—coronary artery disease	3.37e-07	1.36e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GPX1—coronary artery disease	3.33e-07	1.34e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—NOS3—coronary artery disease	3.31e-07	1.34e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PIK3CA—coronary artery disease	3.31e-07	1.34e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—VCAN—coronary artery disease	3.28e-07	1.33e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCND1—coronary artery disease	3.28e-07	1.32e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALDOA—coronary artery disease	3.26e-07	1.31e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CD36—coronary artery disease	3.24e-07	1.31e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PPP2CA—coronary artery disease	3.2e-07	1.29e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MMP9—coronary artery disease	3.19e-07	1.29e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—DCN—coronary artery disease	3.16e-07	1.28e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PLCB1—coronary artery disease	3.12e-07	1.26e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—AKT1—coronary artery disease	3.11e-07	1.26e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GSTP1—coronary artery disease	3.1e-07	1.25e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALDH2—coronary artery disease	3.08e-07	1.24e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GSTP1—coronary artery disease	3.08e-07	1.24e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	3.07e-07	1.24e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—MTHFR—coronary artery disease	3.07e-07	1.24e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—HMOX1—coronary artery disease	3.06e-07	1.23e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL6—coronary artery disease	3.06e-07	1.23e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.06e-07	1.23e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	3.05e-07	1.23e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—HMOX1—coronary artery disease	3.03e-07	1.22e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PTGS2—coronary artery disease	3.03e-07	1.22e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ABCA1—coronary artery disease	3.02e-07	1.22e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CAT—coronary artery disease	3.02e-07	1.22e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—LIPC—coronary artery disease	3e-07	1.21e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—HBA1—coronary artery disease	3e-07	1.21e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	3e-07	1.21e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYP2C19—coronary artery disease	3e-07	1.21e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CAT—coronary artery disease	2.99e-07	1.21e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PIK3CA—coronary artery disease	2.99e-07	1.21e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOC3—coronary artery disease	2.98e-07	1.2e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—LDLR—coronary artery disease	2.96e-07	1.2e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOB—coronary artery disease	2.93e-07	1.18e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.93e-07	1.18e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.93e-07	1.18e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GOT1—coronary artery disease	2.93e-07	1.18e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GGT1—coronary artery disease	2.93e-07	1.18e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—AGT—coronary artery disease	2.92e-07	1.18e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOB—coronary artery disease	2.91e-07	1.17e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GCLC—coronary artery disease	2.89e-07	1.17e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CETP—coronary artery disease	2.89e-07	1.17e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SDC1—coronary artery disease	2.86e-07	1.15e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—VEGFA—coronary artery disease	2.86e-07	1.15e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—APOE—coronary artery disease	2.86e-07	1.15e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GSTM1—coronary artery disease	2.85e-07	1.15e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GSTM1—coronary artery disease	2.83e-07	1.14e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—APOA1—coronary artery disease	2.82e-07	1.14e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—AKT1—coronary artery disease	2.82e-07	1.14e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—LPL—coronary artery disease	2.8e-07	1.13e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—LPL—coronary artery disease	2.77e-07	1.12e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GPX1—coronary artery disease	2.73e-07	1.1e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GPX1—coronary artery disease	2.71e-07	1.09e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.7e-07	1.09e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—AKT1—coronary artery disease	2.7e-07	1.09e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.7e-07	1.09e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.7e-07	1.09e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CD36—coronary artery disease	2.66e-07	1.07e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL6—coronary artery disease	2.65e-07	1.07e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CTGF—coronary artery disease	2.64e-07	1.07e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CD36—coronary artery disease	2.64e-07	1.06e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GSTP1—coronary artery disease	2.63e-07	1.06e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PPP2CA—coronary artery disease	2.63e-07	1.06e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TGFB1—coronary artery disease	2.63e-07	1.06e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.62e-07	1.06e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GOT2—coronary artery disease	2.62e-07	1.06e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	2.6e-07	1.05e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PPP2CA—coronary artery disease	2.6e-07	1.05e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—HMOX1—coronary artery disease	2.59e-07	1.05e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MAPK1—coronary artery disease	2.57e-07	1.04e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CAT—coronary artery disease	2.56e-07	1.03e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—MTHFR—coronary artery disease	2.52e-07	1.02e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—MTHFR—coronary artery disease	2.5e-07	1.01e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PPARG—coronary artery disease	2.49e-07	1e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOB—coronary artery disease	2.48e-07	1e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—POMC—coronary artery disease	2.45e-07	9.91e-06	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—AKT1—coronary artery disease	2.44e-07	9.86e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GSTM1—coronary artery disease	2.42e-07	9.75e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.41e-07	9.71e-06	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—AGT—coronary artery disease	2.39e-07	9.66e-06	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—AGT—coronary artery disease	2.37e-07	9.58e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—LPL—coronary artery disease	2.37e-07	9.57e-06	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOE—coronary artery disease	2.35e-07	9.47e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.33e-07	9.41e-06	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOE—coronary artery disease	2.33e-07	9.39e-06	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOA1—coronary artery disease	2.32e-07	9.36e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GPX1—coronary artery disease	2.31e-07	9.33e-06	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOA1—coronary artery disease	2.3e-07	9.28e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GGT1—coronary artery disease	2.26e-07	9.11e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GOT1—coronary artery disease	2.26e-07	9.11e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CD36—coronary artery disease	2.25e-07	9.09e-06	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ALB—coronary artery disease	2.24e-07	9.03e-06	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PIK3CA—coronary artery disease	2.23e-07	9.01e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PPP2CA—coronary artery disease	2.22e-07	8.98e-06	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.2e-07	8.88e-06	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—NOS3—coronary artery disease	2.14e-07	8.64e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—MTHFR—coronary artery disease	2.13e-07	8.61e-06	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PPARG—coronary artery disease	2.04e-07	8.25e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.03e-07	8.19e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—AGT—coronary artery disease	2.03e-07	8.19e-06	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PPARG—coronary artery disease	2.03e-07	8.17e-06	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—POMC—coronary artery disease	2.02e-07	8.13e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.01e-07	8.11e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—HMOX1—coronary artery disease	2e-07	8.07e-06	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—POMC—coronary artery disease	2e-07	8.06e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOE—coronary artery disease	1.99e-07	8.02e-06	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL6—coronary artery disease	1.98e-07	7.98e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CAT—coronary artery disease	1.97e-07	7.97e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOA1—coronary artery disease	1.96e-07	7.93e-06	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PTGS2—coronary artery disease	1.96e-07	7.9e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOB—coronary artery disease	1.92e-07	7.73e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.88e-07	7.59e-06	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PIK3CA—coronary artery disease	1.86e-07	7.53e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.86e-07	7.52e-06	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ALB—coronary artery disease	1.84e-07	7.41e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—LPL—coronary artery disease	1.83e-07	7.38e-06	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—AKT1—coronary artery disease	1.82e-07	7.36e-06	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ALB—coronary artery disease	1.82e-07	7.35e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GPX1—coronary artery disease	1.79e-07	7.2e-06	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—NOS3—coronary artery disease	1.76e-07	7.09e-06	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—NOS3—coronary artery disease	1.74e-07	7.03e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CD36—coronary artery disease	1.74e-07	7.02e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PPARG—coronary artery disease	1.73e-07	6.99e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.72e-07	6.93e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—POMC—coronary artery disease	1.71e-07	6.89e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.65e-07	6.65e-06	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.61e-07	6.49e-06	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.59e-07	6.43e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—AGT—coronary artery disease	1.57e-07	6.32e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALB—coronary artery disease	1.56e-07	6.28e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOE—coronary artery disease	1.53e-07	6.19e-06	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—AKT1—coronary artery disease	1.52e-07	6.15e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOA1—coronary artery disease	1.52e-07	6.12e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NOS3—coronary artery disease	1.49e-07	6.01e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PTGS2—coronary artery disease	1.36e-07	5.5e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PPARG—coronary artery disease	1.34e-07	5.39e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—POMC—coronary artery disease	1.32e-07	5.32e-06	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PIK3CA—coronary artery disease	1.2e-07	4.86e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALB—coronary artery disease	1.2e-07	4.85e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NOS3—coronary artery disease	1.15e-07	4.64e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.05e-07	4.24e-06	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PIK3CA—coronary artery disease	9.89e-08	3.99e-06	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—AKT1—coronary artery disease	9.84e-08	3.97e-06	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PIK3CA—coronary artery disease	9.8e-08	3.96e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PIK3CA—coronary artery disease	8.38e-08	3.38e-06	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—AKT1—coronary artery disease	8.08e-08	3.26e-06	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—AKT1—coronary artery disease	8.01e-08	3.23e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—AKT1—coronary artery disease	6.84e-08	2.76e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PIK3CA—coronary artery disease	6.47e-08	2.61e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—AKT1—coronary artery disease	5.28e-08	2.13e-06	CbGpPWpGaD
